Atezolizumab for Advanced Alveolar Soft Part Sarcoma

2023129 citationsJournal Articlegreen Open Access

Authors

Alice P. Chen · Johns Hopkins University

Elad Sharon · Johns Hopkins University

Geraldine O’Sullivan Coyne · Johns Hopkins University

Nancy Moore · Johns Hopkins University

Jared C. Foster · Johns Hopkins University

James Hu · University of Southern California

Brian A. Van Tine ·

Abstract

Atezolizumab was effective at inducing sustained responses in approximately one third of patients with advanced ASPS. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT03141684.).

Topics & Keywords

Sarcoma Diagnosis and Treatment Medical Imaging and Pathology Studies Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 389, Issue 10, pp. 911-921

DOI: 10.1056/nejmoa2303383

Field-Weighted Citation Impact: 32.95